Severe Combined Immunodeficiency in a Child With a Healthy Adenosine Deaminase Deficient Mother

Pediatric Research - United States
doi 10.1203/00006450-198312000-00002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

T Lymphocyte Ontogeny in Adenosine Deaminase-Deficient Severe Combined Immune Deficiency After Treatment With Polyethylene Glycol-Modified Adenosine Deaminase.

Journal of Clinical Investigation
Medicine
1993English

Adenosine Deaminase-Deficient Mice Generated Using a Two-Stage Genetic Engineering Strategy Exhibit a Combined Immunodeficiency

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Overproduction of Adenine Deoxynucleosides and Deoxynucletides in Adenosine Deaminase Deficiency With Severe Combined Immunodeficiency Disease.

Journal of Clinical Investigation
Medicine
1978English

Severe Combined Immunodeficency Accompanied With Adenosine Deaminase (ADA) Deficency.

Japanese Journal of Clinical Immunology
1988English

Psy211 - The Clinical, Humanistic, and Economic Burden of Adenosine Deaminase (Ada) Severe Combined Immunodeficiency (Scid): A Systematic Literature Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

279. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID)

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

30. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID) Using a Γ-Retroviral Vector

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Structure of Adenosine Deaminase mRNAs From Normal and Adenosine Deaminase-Deficient Human Cell Lines.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1984English

Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation

PharmacoEconomics - Open
Health PolicyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy